Gayatri Bioorganics Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 15/04/2026 ,inter alia, to consider and approve Reduction of capital
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Gayatri BioOrganics Ltd has informed BSE that its Board of Directors will meet on 15th April 2026 to consider a Scheme of Reduction of Share Capital. This is a scheduled board meeting under SEBI Listing Regulations. The trading window for insiders has been closed from 1st April 2026 until 48 hours after the audited financial results for Q4 and FY ended March 2026 are declared. Capital reduction typically involves cancelling shares or reducing face value, often used to write off accumulated losses or restructure the company's capital base.
Capital reduction can be positive if it eliminates accumulated losses and improves financial health, but may also dilute shareholder value depending on the structure. Investors should monitor for further announcements on the specific scheme details and NCLT approval process.